CADL · Candel Therapeutics, Inc. · Share Buybacks
$5.16
-0.16 (-3.04%)
At close · Nov 19
Return incl. dividend (before tax)
Market Cap
$402.43M
Shares
78.45M
Volume · Nov 19
1.16M
Avg daily vol (3M)
1.26M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-08-14 | 2026-11-12 | $50,000,000 | — | — | 8-K , filed 2026-11-12 |
Key facts
CIK
1841387
CUSIP
137404109
13F (30d)
151 filings
137 filers
Visit website
Investor relations